This item is a preprint posted on bioRxiv titled "Short-term, Long-term, and Genetic Determinants of Human Plasma Proteome Variability" (doi: https://doi.org/10.64898/2026.07.30.741635). The title indicates the study addresses temporal aspects of protein level changes in plasma—both short-term and long-term—and the role of genetic determinants in shaping interindividual differences in the plasma proteome. The bioRxiv record explicitly notes that the manuscript is a preprint and has not been peer reviewed.
The author list on the bioRxiv page includes David Benacom (corresponding author: david.benacom@gmail.com) and a multidisciplinary team with affiliations across several institutions: Stanford University; University of North Carolina at Chapel Hill; UT Southwestern; University of California, San Francisco; The Lundquist Institute/Harbor-UCLA Medical Center; University of Virginia School of Medicine; Baylor College of Medicine; Beth Israel Deaconess Medical Center; University of Pennsylvania; and Harvard Medical School, among others.
The record provides individual author names and institutional affiliations; no funding statements, competing interest disclosures, or submission history were included in the provided excerpt.
Based on the title alone, the manuscript appears to investigate three related questions:
How much variability in human plasma protein concentrations occurs on short-term timescales (for example, hours to days).
How much variability occurs on long-term timescales (for example, months to years).
Which genetic determinants (for example, loci or variants) contribute to interindividual differences in plasma protein levels and how these genetic effects interact with temporal variability.
These topics are directly relevant to biomarker research, the design and interpretation of proteomic studies, and efforts to map protein quantitative trait loci (pQTLs). However, the source excerpt does not present any study-specific definitions for "short-term" or "long-term," nor does it define the genetic analyses performed.
The accessible information on the source page includes:
Full manuscript title and DOI.
Complete author list with institutional affiliations.
Corresponding author contact email.
The preprint status statement indicating the work has not been peer reviewed.
What is not present in the excerpt: abstract, keywords, background, hypothesis, methods, participant or sample descriptions, proteomic technologies used, statistical methods, primary findings, numerical results, figures, tables, or conclusions.
The provided source text does not contain any of the following critical elements needed to summarize study results or to appraise methodological quality:
Study design (cohort, cross-sectional, longitudinal, case-control, interventional).
Sample size and participant characteristics (age, sex, health status, inclusion/exclusion criteria).
Biospecimen collection protocols (timing, fasting state, anticoagulant, storage conditions).
Proteomic measurement platform(s) (mass spectrometry, antibody arrays, aptamer-based assays, etc.).
Quality control procedures for proteomic data.
Genetic data generation and processing details (genotyping arrays, sequencing, imputation, ancestry adjustments).
Statistical models used to estimate short-term vs long-term variability and to detect genetic associations.
Specific proteins, pathways, or genetic loci implicated.
Quantitative results (variance components, effect sizes, p-values, confidence intervals) and their interpretation.
Any validation experiments or replication cohorts.
Because these elements are absent from the provided excerpt, it is not possible to report on the study findings, performance metrics, or to evaluate validity and generalizability from this source text alone.
The title highlights an important and timely topic: the degree to which plasma protein levels fluctuate over time and the extent to which inherited variation shapes those levels. Answers to these questions influence how clinicians and researchers interpret single-timepoint biomarker measurements, design longitudinal biomarker studies, and prioritize proteins for use in diagnostic or prognostic tests.
However, readers should not assume any specific results or recommendations based on the title and author list alone. To assess methods, findings, and clinical or research implications, consult the full preprint PDF on bioRxiv or contact the corresponding author using the provided email address. The preprint status also indicates that conclusions should be treated as provisional until peer review and formal publication occur.
Retrieve and review the full preprint on the bioRxiv page for complete methods, data, results, and figures.
Evaluate sample size, cohort composition, proteomic platform, and statistical approach to judge applicability to your setting.
Check whether the authors provide data or code availability statements to support reproducibility.
Monitor for subsequent peer-reviewed publication or related follow-up studies that validate and extend the reported analyses.
Note: All statements above are derived solely from the metadata and title available in the provided bioRxiv excerpt. Specific experimental details and study results were not included in the source text and therefore are not reported here.